BR112012017535A2 - uso de compostos de vanádio para cicatrização de osso - Google Patents
uso de compostos de vanádio para cicatrização de ossoInfo
- Publication number
- BR112012017535A2 BR112012017535A2 BR112012017535A BR112012017535A BR112012017535A2 BR 112012017535 A2 BR112012017535 A2 BR 112012017535A2 BR 112012017535 A BR112012017535 A BR 112012017535A BR 112012017535 A BR112012017535 A BR 112012017535A BR 112012017535 A2 BR112012017535 A2 BR 112012017535A2
- Authority
- BR
- Brazil
- Prior art keywords
- bone healing
- vanadium compounds
- vanadium
- compounds
- healing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/26—Iron; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/32—Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/54—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/10—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
- A61L2300/102—Metals or metal compounds, e.g. salts such as bicarbonates, carbonates, oxides, zeolites, silicates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/45—Mixtures of two or more drugs, e.g. synergistic mixtures
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/02—Materials or treatment for tissue regeneration for reconstruction of bones; weight-bearing implants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Biomedical Technology (AREA)
- Inorganic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Physical Education & Sports Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Neurosurgery (AREA)
- Molecular Biology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Immunology (AREA)
- Cell Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Biotechnology (AREA)
- Virology (AREA)
- Zoology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Materials For Medical Uses (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US29523410P | 2010-01-15 | 2010-01-15 | |
PCT/US2011/021296 WO2011088318A1 (en) | 2010-01-15 | 2011-01-14 | Use of vanadium compounds to accelerate bone healing |
Publications (1)
Publication Number | Publication Date |
---|---|
BR112012017535A2 true BR112012017535A2 (pt) | 2019-09-24 |
Family
ID=44304667
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112012017535A BR112012017535A2 (pt) | 2010-01-15 | 2011-01-14 | uso de compostos de vanádio para cicatrização de osso |
Country Status (7)
Country | Link |
---|---|
US (2) | US8936804B2 (pt) |
EP (1) | EP2523672B1 (pt) |
JP (1) | JP5878477B2 (pt) |
KR (1) | KR20120113265A (pt) |
BR (1) | BR112012017535A2 (pt) |
CA (1) | CA2787208C (pt) |
WO (1) | WO2011088318A1 (pt) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8936804B2 (en) | 2010-01-15 | 2015-01-20 | Rutgers, The State University Of New Jersey | Use of vanadium compounds to accelerate bone healing |
US20170035803A1 (en) * | 2010-12-10 | 2017-02-09 | Rutgers, The State University Of New Jersey | Insulin-mimetic local therapeutic adjuncts for enhancing spinal fusion |
WO2013006798A1 (en) | 2011-07-06 | 2013-01-10 | University Of Medicine And Dentistry Of New Jersey | Vandium compounds as therapeutic adjuncts for cartilage regeneration and repair |
EP2648718B1 (en) * | 2010-12-10 | 2019-05-08 | Rutgers, the State University of New Jersey | Implantable devices coated with insulin-mimetic agent composites and methods thereof |
US20140322292A1 (en) | 2010-12-10 | 2014-10-30 | Rutgers, The State University Of New Jersey | Insulin-mimetics as therapeutic adjuncts for bone regeneration |
JP6214548B2 (ja) * | 2011-11-29 | 2017-10-18 | ラトガース,ザ ステート ユニバーシティ オブ ニュー ジャージー | 骨再生のための治療補助薬としてのインスリン−疑似剤 |
AU2013334111A1 (en) * | 2012-10-25 | 2015-05-28 | Rutgers, The State University Of New Jersey | Insulin-mimetic local therapeutic adjuncts for enhancing spinal fusion |
WO2018089795A1 (en) | 2016-11-10 | 2018-05-17 | Qoravita LLC | System and method for applying a low frequency magnetic field to biological tissues |
GB2590692A (en) * | 2019-12-24 | 2021-07-07 | Corthotec Ltd | Composition for improved bone fracture healing |
CN113121118A (zh) * | 2021-03-08 | 2021-07-16 | 四川大学 | 一种钒掺杂硅钙磷介孔生物活性玻璃粉 |
Family Cites Families (65)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3773919A (en) | 1969-10-23 | 1973-11-20 | Du Pont | Polylactide-drug mixtures |
DE2314573C2 (de) | 1973-03-23 | 1986-12-18 | Werner Dipl.-Ing. 8000 München Kraus | Gerät zur Förderung von Heilungsprozessen |
US4657760A (en) | 1979-03-20 | 1987-04-14 | Ortho Pharmaceutical Corporation | Methods and compositions using monoclonal antibody to human T cells |
US5019383A (en) | 1981-01-09 | 1991-05-28 | New York Blood Center, Inc. | Fatty acid carriers for synthetic peptides |
IE52535B1 (en) | 1981-02-16 | 1987-12-09 | Ici Plc | Continuous release pharmaceutical compositions |
US4530840A (en) | 1982-07-29 | 1985-07-23 | The Stolle Research And Development Corporation | Injectable, long-acting microparticle formulation for the delivery of anti-inflammatory agents |
US4725442A (en) | 1983-06-17 | 1988-02-16 | Haynes Duncan H | Microdroplets of water-insoluble drugs and injectable formulations containing same |
US4622219A (en) | 1983-06-17 | 1986-11-11 | Haynes Duncan H | Method of inducing local anesthesia using microdroplets of a general anesthetic |
US4891225A (en) | 1984-05-21 | 1990-01-02 | Massachusetts Institute Of Technology | Bioerodible polyanhydrides for controlled drug delivery |
US5206344A (en) | 1985-06-26 | 1993-04-27 | Cetus Oncology Corporation | Interleukin-2 muteins and polymer conjugation thereof |
IT1198449B (it) | 1986-10-13 | 1988-12-21 | F I D I Farmaceutici Italiani | Esteri di alcoli polivalenti di acido ialuronico |
US4834757A (en) | 1987-01-22 | 1989-05-30 | Brantigan John W | Prosthetic implant |
US5061286A (en) | 1989-08-18 | 1991-10-29 | Osteotech, Inc. | Osteoprosthetic implant |
JP2811331B2 (ja) * | 1989-10-02 | 1998-10-15 | ゼリア新薬工業株式会社 | 骨形成促進剤 |
US5225212A (en) | 1989-10-20 | 1993-07-06 | Liposome Technology, Inc. | Microreservoir liposome composition and method |
US6099457A (en) | 1990-08-13 | 2000-08-08 | Endotech, Inc. | Endocurietherapy |
JP3245202B2 (ja) * | 1991-11-14 | 2002-01-07 | 松尾 壽之 | 新規骨形成誘導蛋白質及びそれを有効成分とする骨形成誘導剤 |
WO1994012158A1 (en) | 1992-12-02 | 1994-06-09 | Alkermes Controlled Therapeutics, Inc. | Controlled release growth hormone containing microspheres |
CN1156255C (zh) | 1993-10-01 | 2004-07-07 | 美商-艾克罗米德公司 | 脊椎植入物 |
US5871779A (en) | 1994-01-18 | 1999-02-16 | Mount Sinai Hospital Corporation | Treatment of arthropathies with vanadate compounds or analogues thereof |
JP3738281B2 (ja) * | 1994-07-22 | 2006-01-25 | アベンティス ファーマ株式会社 | 新規な骨芽細胞増殖因子 |
AU695323B2 (en) | 1994-09-09 | 1998-08-13 | Takeda Chemical Industries Ltd. | Sustained release preparation containing metal salt of a peptide |
US5614206A (en) | 1995-03-07 | 1997-03-25 | Wright Medical Technology, Inc. | Controlled dissolution pellet containing calcium sulfate |
US5545661A (en) * | 1995-05-16 | 1996-08-13 | Eli Lilly And Company | Methods for inhibiting bone loss with bis-pyrone oxovanadium compounds |
PT831787E (pt) | 1995-06-07 | 2002-02-28 | Alkermes Inc | Composicao para libertacao sustentada da hormona de crescimento humano |
ZA965368B (en) | 1995-07-14 | 1997-01-14 | Novo Nordisk As | A pharmaceutical formulation |
DE29600241U1 (de) | 1996-01-09 | 1996-02-29 | Gebo-Armaturen GmbH, 58332 Schwelm | Lösbare Rohrverbindung für Kunststoffrohre |
US5842477A (en) | 1996-02-21 | 1998-12-01 | Advanced Tissue Sciences, Inc. | Method for repairing cartilage |
US7041641B2 (en) | 1997-03-20 | 2006-05-09 | Stryker Corporation | Osteogenic devices and methods of use thereof for repair of endochondral bone and osteochondral defects |
NL1006681C2 (nl) | 1997-07-29 | 1999-02-08 | Gho St Holding Bv | Toepassing van fysiologisch acceptabele vanadiumverbindingen, -zouten en -complexen. |
AU6184499A (en) * | 1998-10-28 | 2000-05-15 | University Of British Columbia, The | Organic vanadium(iii) complexes and their use |
CN100441688C (zh) | 1999-04-30 | 2008-12-10 | 埃默里大学 | Lim矿化蛋白剪接变体 |
US6630153B2 (en) | 2001-02-23 | 2003-10-07 | Smith & Nephew, Inc. | Manufacture of bone graft substitutes |
EP2085055B1 (en) | 2000-10-24 | 2012-06-06 | Warsaw Orthopedic, Inc. | Spinal fusion devices |
US6958359B1 (en) | 2000-11-15 | 2005-10-25 | Parker Hughes Institute | Vanadium compounds as anti-angiogenic agents |
WO2003105752A2 (en) | 2002-05-02 | 2003-12-24 | Osteoscreen, Inc. | Methods and compositions for stimulating bone growth using nitric oxide releasing bisphosphonate conjugates (no-bisphosphonate) |
US7291179B2 (en) | 2002-06-24 | 2007-11-06 | Wright Medical Technology, Inc. | Bone graft substitute composition |
DE10238161A1 (de) * | 2002-08-15 | 2004-02-26 | Köhler Pharma GmbH | Mineralstoff-Ampulle für die mucosale und topische Wirkstoffapplikation |
US20040121025A1 (en) * | 2002-12-20 | 2004-06-24 | Mckee Dwight | Oral composition for the treatment and prevention of bone loss |
CN100344334C (zh) | 2002-12-31 | 2007-10-24 | 华中科技大学同济医学院附属协和医院 | 骨组织填充材料 |
MXPA05008653A (es) | 2003-02-14 | 2006-04-27 | Depuy Spine Inc | Dispositivo de fusion intervertebral formado in situ. |
US9199005B2 (en) | 2003-10-01 | 2015-12-01 | New York University | Calcium phosphate-based materials containing zinc, magnesium, fluoride and carbonate |
US7419680B2 (en) | 2003-10-01 | 2008-09-02 | New York University | Calcium phosphate-based materials containing zinc, magnesium, fluoride and carbonate |
US7208172B2 (en) | 2003-11-03 | 2007-04-24 | Medlogics Device Corporation | Metallic composite coating for delivery of therapeutic agents from the surface of implantable devices |
US9016221B2 (en) | 2004-02-17 | 2015-04-28 | University Of Florida Research Foundation, Inc. | Surface topographies for non-toxic bioadhesion control |
US7189409B2 (en) | 2004-03-09 | 2007-03-13 | Inion Ltd. | Bone grafting material, method and implant |
EP1743021B1 (en) | 2004-03-19 | 2014-03-26 | Cytori Therapeutics, Inc. | Method of preparing regenerative cells on a cell carrier and cell carrier containment device |
EP1812090A1 (en) | 2004-10-28 | 2007-08-01 | Microchips, Inc. | Orthopedic and dental implant devices providing controlled drug delivery |
US20070027543A1 (en) | 2005-08-01 | 2007-02-01 | Gimble Jeffrey M | Use of adipose tissue-derived stromal cells in spinal fusion |
SG2014011944A (en) | 2005-08-30 | 2014-08-28 | Advanced Tech Materials | Boron ion implantation using alternative fluorinated boron precursors, and formation of large boron hydrides for implantation |
US20070073385A1 (en) | 2005-09-20 | 2007-03-29 | Cook Incorporated | Eluting, implantable medical device |
EP1991284A4 (en) | 2006-02-01 | 2012-07-04 | Jake Barralet | BIOIMPLANTS FOR USE IN TISSUE GROWTH |
WO2007098479A2 (en) * | 2006-02-21 | 2007-08-30 | University Of Medicine And Dentistry Of New Jersey | Localized insulin delivery for bone healing |
US9089437B2 (en) | 2006-10-16 | 2015-07-28 | Pioneer Surgical Technology, Inc. | Fusion device, systems and methods thereof |
WO2008048647A1 (en) | 2006-10-17 | 2008-04-24 | Cythera, Inc. | Modulation of the phosphatidylinositol-3-kinase pathway in the differentiation of human embryonic stem cells |
DE102007007865A1 (de) | 2007-02-14 | 2008-08-21 | Jennissen, Herbert, Prof. Dr. | Verfahren zur Herstellung von lagerfähigen Implantaten mit einer ultrahydrophilen Oberfläche |
EP2219823A2 (en) | 2007-10-16 | 2010-08-25 | HKPB Scientific Limited | Surface coating processes and uses of same |
CN101878324B (zh) | 2007-10-19 | 2013-04-03 | 比奥因特费斯公司 | 新颖组合物和相关方法、涂料和物件 |
WO2009068285A1 (de) | 2007-11-27 | 2009-06-04 | Johnson Controls Gmbh | Optische anordnung |
CN102014975A (zh) * | 2008-02-29 | 2011-04-13 | 史密夫和内修有限公司 | 用于生物医学应用的梯度涂层 |
JP2011513034A (ja) | 2008-03-10 | 2011-04-28 | マーフライ・2・リミテッド・パートナーシップ | 骨セメント組成物 |
US20120141599A1 (en) | 2009-04-01 | 2012-06-07 | Difusion Technologies, Inc. | Regulation Of Bone Growth Using Zeolite In Combination With Bone Graft Substitutes |
US8936804B2 (en) | 2010-01-15 | 2015-01-20 | Rutgers, The State University Of New Jersey | Use of vanadium compounds to accelerate bone healing |
EP2648718B1 (en) * | 2010-12-10 | 2019-05-08 | Rutgers, the State University of New Jersey | Implantable devices coated with insulin-mimetic agent composites and methods thereof |
JP6214548B2 (ja) | 2011-11-29 | 2017-10-18 | ラトガース,ザ ステート ユニバーシティ オブ ニュー ジャージー | 骨再生のための治療補助薬としてのインスリン−疑似剤 |
-
2011
- 2011-01-14 US US13/522,075 patent/US8936804B2/en active Active
- 2011-01-14 CA CA2787208A patent/CA2787208C/en active Active
- 2011-01-14 JP JP2012549109A patent/JP5878477B2/ja active Active
- 2011-01-14 WO PCT/US2011/021296 patent/WO2011088318A1/en active Application Filing
- 2011-01-14 EP EP11733440.9A patent/EP2523672B1/en active Active
- 2011-01-14 KR KR1020127021191A patent/KR20120113265A/ko not_active Application Discontinuation
- 2011-01-14 BR BR112012017535A patent/BR112012017535A2/pt not_active IP Right Cessation
-
2014
- 2014-12-10 US US14/566,237 patent/US9730946B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
WO2011088318A1 (en) | 2011-07-21 |
JP5878477B2 (ja) | 2016-03-08 |
US20130171094A1 (en) | 2013-07-04 |
US9730946B2 (en) | 2017-08-15 |
EP2523672A1 (en) | 2012-11-21 |
AU2011205741A1 (en) | 2012-08-16 |
KR20120113265A (ko) | 2012-10-12 |
EP2523672A4 (en) | 2013-05-08 |
US20150099804A1 (en) | 2015-04-09 |
CA2787208C (en) | 2017-06-06 |
US8936804B2 (en) | 2015-01-20 |
JP2013517287A (ja) | 2013-05-16 |
CA2787208A1 (en) | 2011-07-21 |
EP2523672B1 (en) | 2016-07-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112012017535A2 (pt) | uso de compostos de vanádio para cicatrização de osso | |
BR112013014943A2 (pt) | compostos úteis para o tratamento de aids | |
CO6930321A2 (es) | Curación de tejidos | |
BR112013023611A2 (pt) | instrumentos de grampeamento cirúrgico | |
BR112013023604A2 (pt) | instrumentos cirúrgicos de fixação | |
CO6870033A2 (es) | Compuestos terapéuticos y métodos de uso relacionados | |
BR112013002845A2 (pt) | combinação de susbtâncias ativas | |
BR112012027707A2 (pt) | dispositivo médico para tratar tecido rígido | |
UY33094A (es) | Procedimiento para la preparacion de dronedarona | |
BR112014005914A2 (pt) | Produto para cicatrização de feridas tecidulares | |
BR112013008017A2 (pt) | análogos de carba-nucleosídeo 2-flúor substituídos para tratamento antiviral | |
BR112013006016A2 (pt) | compostos de azabenzotiazol, composições e métodos de uso | |
ES2603028T8 (es) | Procedimiento para la preparación de (Z)-alfa-fluoro-beta-amino-acrilaldehídos sustituidos | |
DK2568889T3 (da) | Kirurgisk instrument | |
DK2593060T3 (da) | Engangsble | |
BR112013022523A2 (pt) | uso de glicopirrolato para o tratamento de taquicardia | |
BR112012004836A2 (pt) | pirazinilpiridinas úteis para o tratamento de doenças proliferativas | |
DK2436342T3 (da) | Indretning til påføring af knoglesubstitutionsmateriale | |
BR112015006512A2 (pt) | composição para tratar tecidos biológicos danificados | |
ES1072245Y (es) | Dispositivo de encerrojamiento para corazon de punta movil | |
BR112013006796A2 (pt) | ferramenta para perfurar o tecido ósseo | |
CO7020857A2 (es) | Procedimiento para la preparación de complejos de 68ga | |
BR112013014699A2 (pt) | meios de fixação para um produto absorvente | |
CR20120395A (es) | Uso farmacéutico de compuestos multicíclicos como agentes anti-síndrome de inmunodeficiencia adquirida | |
BR112013014205A2 (pt) | implante cirúrgico |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] | ||
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2543 DE 01-10-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |